Personal information

Verified email addresses

Verified email domains

glioma, boron neutron capture therapy, Brain tumor, neuro-oncology, stroke, radiation oncology, surgical oncology
Japan

Activities

Employment (4)

Osaka Medical and Pharmaceutical University: Takatsuki, Osaka, JP

2021-04-01 to present | Associate Professor (Faculty of Medicine, Neurosurgery)
Employment
Source: Self-asserted source
Shinji Kawabata

Osaka Medical College: Takatsuki, Osaka, JP

2017-06-01 to 2021-03-31 | Associate professor (Faculty of Medicine, Neurosurgery)
Employment
Source: Self-asserted source
Shinji Kawabata

Osaka Medical College: Takatsuki, Osaka, JP

2001-03-01 to 2017-05-31 | Junior Associate Professor (Faculty of Medicine, Neurosurgery)
Employment
Source: Self-asserted source
Shinji Kawabata

The Ohio State University: Columbus, Ohio, US

2004-04-01 to 2006-03-31 | visiting research associate (Faculty of Medicine, Pathology)
Employment
Source: Self-asserted source
Shinji Kawabata

Education and qualifications (1)

Osaka Medical College: Takatsuki, Osaka, JP

1996-04-01 to 2000-03-31 | Ph.D. (Graduate School of Medicine, Neurosurgery)
Education
Source: Self-asserted source
Shinji Kawabata

Funding (31)

Development of a new neutron ambient dose equivalent rate monitor suitable for accelerator-based boron neutron capture therapy

2023-04-01 to 2026-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 23H03762
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Technology platform for clinical application of multi-targeted neutron capture therapy for brain tumors

2023-04-01 to 2026-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 23H03024
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

脊髄神経膠腫に対するホウ素中性子捕捉療法の確立に向けた基盤研究

2022-04-01 to 2025-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 22K09270
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

悪性神経膠腫・悪性髄膜種において新規分子標的となる転写キメラの同定とその機能解析

2021-04-01 to 2024-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 21K09165
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Establishment of multi-target neutron capture therapy with multiple boron drugs for brain tumor

2020-04-01 to 2023-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 20H03797
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Investigation regarding the progress of therapeutic effect of BNCT using folate receptor-targeted boron compound which be administered by convection enhanced delivery

2020-04-01 to 2023-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 20K09399
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Pseudoprogressionの病態解明と画像診断法の確立

2020-04-01 to 2023-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 20K09336
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

神経膠腫の浸潤機序解析と浸潤能を標的とした先駆的治療法の開発

2020-04-01 to 2023-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 20K09359
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Research on irradiation methods and quality assurance that can freely change the treatment depth and region in BNCT

2019-04-01 to 2022-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 19H04485
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Development of real-time radiation detector capable of measuring with quality discrimination in neutron capture therapy

2018-06-29 to 2021-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 18K19916
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

悪性脳腫瘍におけるPDT効果予測ならびに悪性度及び分子生物学的特性予測マップ作成

2018-04-01 to 2021-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 18K09011
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Clinical trial of boron neutron capture therapy with the combination of successive bevacizumab treatments for recurrent malignant gliomas

2017-04-01 to 2020-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 17K10877
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Development of novel drugs for malignant brain tumors targeting transport protein TSPO and boron neutron capture therapy

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

分子標的時代における放射線壊死の病態解明と新規診断・新規治療への挑戦

2017-04-01 to 2020-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 17K10911
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Usefulness of a super selective arterial infusion therapy of a novel boronated porphyrin for BNCT and PDT

2017-04-01 to 2019-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 17K16666
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

The development of new AR-type three-dimensional imaging modalities with the aim of application to the cranial nerve surgery

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

The development of the displacement detecting device of the irradiation position with the simple rapid high-precision method of determining the optimal irradiation position of BNCT patients

Development of early treatment effect determination method by image analysis using a PET metabolic images before and after brain tumor treatment

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Overcome bevacizumab treatment and beyond bevacizumab refractory radiation necrosis

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Usefulness of boron neutron capture therapy using tumor directional boron cluster qualified kojic acid

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

The development of real-time three-dimensional dose evaluation system by the prompt gamma-ray for neutron capture therapy

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

The significance of amino acid PET which considered blood perfusion in diagnosis of recurrent malignant brain tumor

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Tumor-selective high LET and high RBE particles can overcome the radiation-resistant glioma stem cells

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

初発膠芽腫に対する新規放射線化学療法による有効治療法確立のための臨床研究

2011-04-01 to 2013-03-31 | Grant
Ministry of Health Labour and Welfare (Tokyo, JP)
GRANT_NUMBER: 201114047A
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

初発膠芽腫に対する新規放射線化学療法による有効治療法確立のための臨床研究

2011-04-01 to 2013-03-31 | Grant
Ministry of Health Labour and Welfare (Tokyo, JP)
GRANT_NUMBER: 201309008A
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

初発膠芽腫に対する新規放射線化学療法による有効治療法確立のための臨床研究

2011-04-01 to 2013-03-31 | Grant
Ministry of Health Labour and Welfare (Tokyo, JP)
GRANT_NUMBER: 201215018A
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

New treatment using bevacizumab and novel diagnostic method for radiation necrosis

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Therapeutic effect improvement by new boron neutron capture therapy with amino acid - BSH

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Usefullness of novel boronated porphyrins for both BNCT and PDT

2008-01-01 to 2010-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 20591728
Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Development of boron neutron capture therapy for the standard treatment of malignant brain tumors

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Usefulness of the CED as a method of administration of the boron compound embedded liposome in neutron capture therapy

Source: Self-asserted source
Shinji Kawabata via DimensionsWizard

Peer review (47 reviews for 16 publications/grants)

Review activity for Applied radiation and isotopes. (7)
Review activity for Cancer biotherapy & radiopharmaceuticals. (1)
Review activity for Cancer science. (1)
Review activity for Cancers. (6)
Review activity for Cells. (1)
Review activity for Current oncology. (6)
Review activity for Diagnostics. (2)
Review activity for Journal of clinical medicine. (2)
Review activity for Journal of neuro-oncology. (1)
Review activity for Journal of neuro-oncology. (1)
Review activity for Metabolites. (2)
Review activity for Nanomaterials. (2)
Review activity for Neurology International (1)
Review activity for Nuclear science and techniques. (8)
Review activity for Pharmaceutics. (5)
Review activity for Quantitative imaging in medicine and surgery. (1)